Search Results 261-270 of 19306 for autoimmune hepatitis
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...
Referral timing is essential to ensure patients with advanced liver disease experience optimal transplant results. It is important to avoid referring a ...
This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic response (SVR) after ...
Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia that affects digestive tract motility. Although rare, the condition can be ...
Alcoholic liver disease. Inflammation of the liver. Scarring of the liver, called cirrhosis. Hepatitis A, B or C. Infectious mononucleosis, also called mono ...
... Liver Disease or Post-Liver Transplant Jacksonville, FL ... A Study to Evaluate and Monitor Hepatitis Activity in Hepatitis ... A Study of the Frequency of ...
... liver disease, and they present a detailed approach to the management of ... "Weight loss can improve liver health and overall health, regardless of the type of ...
This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.
... autoimmune diseases. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.